Stephen Toon
Corporate Officer/Principal at The University of Manchester
Profile
Stephen Toon is an Honorary Lecturer at The University of Manchester and a Member of the Royal Pharmaceutical Society of Great Britain.
He previously held positions as the Chief Executive Officer at Medeval Group Ltd., Director at XenologiQ Ltd., President, Managing Director & Director at Certara UK Ltd., and Senior Vice President at ICON plc.
Dr. Toon has an undergraduate degree from the University of Bath and graduate and doctorate degrees from The University of Manchester.
Stephen Toon active positions
Companies | Position | Start |
---|---|---|
The University of Manchester | Corporate Officer/Principal | - |
Royal Pharmaceutical Society of Great Britain
Royal Pharmaceutical Society of Great Britain Miscellaneous Commercial ServicesCommercial Services The Royal Pharmaceutical Society of Great Britain provides expertise and support to its member pharmacists. The private company is based in Great Britain. Alex MacKinnon has been the CEO of the British company since 2010. | Corporate Officer/Principal | - |
Former positions of Stephen Toon
Companies | Position | End |
---|---|---|
Certara UK Ltd.
Certara UK Ltd. BiotechnologyHealth Technology Certara UK Ltd. provides platforms for the modeling and simulation of pharmacokinetics and pharmacodynamics in virtual human populations and virtual laboratory animals. The company was founded by Geoffrey Thomas Tucker, Amin Rostami-Hodjegan, and John Evans on May 15, 2001 and is headquartered in London, the United Kingdom. | Chief Executive Officer | 28/02/2023 |
XenologiQ Ltd.
XenologiQ Ltd. Miscellaneous Commercial ServicesCommercial Services XenologiQ Ltd. provides consultancy services for the drug industry. It offers services in the areas of pharmacokinetic pharmacodynamics modelling, systems pharmacology and training. The firm projects include conference presentations; dose prediction for novel biological drugs and nerve growth factor pathways systems pharmacology. The company was founded in 2011 and is headquartered in London, United Kingdom. | Director/Board Member | 31/12/2019 |
Medeval Group Ltd.
Medeval Group Ltd. Miscellaneous Commercial ServicesCommercial Services Part of ICON plc, Medeval Group Ltd. is a British company that carries out clinical pharmacology studies on behalf of pharmaceutical and biotechnology companies. The company is based in Manchester, UK. Medeval Group was acquired by ICON plc on January 24, 2003 for $22.64 million. | President | - |
ICON PUBLIC LIMITED COMPANY | Corporate Officer/Principal | - |
Training of Stephen Toon
The University of Manchester | Doctorate Degree |
University of Bath | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 1 |
---|---|
ICON PUBLIC LIMITED COMPANY | Commercial Services |
Private companies | 4 |
---|---|
Certara UK Ltd.
Certara UK Ltd. BiotechnologyHealth Technology Certara UK Ltd. provides platforms for the modeling and simulation of pharmacokinetics and pharmacodynamics in virtual human populations and virtual laboratory animals. The company was founded by Geoffrey Thomas Tucker, Amin Rostami-Hodjegan, and John Evans on May 15, 2001 and is headquartered in London, the United Kingdom. | Health Technology |
Royal Pharmaceutical Society of Great Britain
Royal Pharmaceutical Society of Great Britain Miscellaneous Commercial ServicesCommercial Services The Royal Pharmaceutical Society of Great Britain provides expertise and support to its member pharmacists. The private company is based in Great Britain. Alex MacKinnon has been the CEO of the British company since 2010. | Commercial Services |
Medeval Group Ltd.
Medeval Group Ltd. Miscellaneous Commercial ServicesCommercial Services Part of ICON plc, Medeval Group Ltd. is a British company that carries out clinical pharmacology studies on behalf of pharmaceutical and biotechnology companies. The company is based in Manchester, UK. Medeval Group was acquired by ICON plc on January 24, 2003 for $22.64 million. | Commercial Services |
XenologiQ Ltd.
XenologiQ Ltd. Miscellaneous Commercial ServicesCommercial Services XenologiQ Ltd. provides consultancy services for the drug industry. It offers services in the areas of pharmacokinetic pharmacodynamics modelling, systems pharmacology and training. The firm projects include conference presentations; dose prediction for novel biological drugs and nerve growth factor pathways systems pharmacology. The company was founded in 2011 and is headquartered in London, United Kingdom. | Commercial Services |
- Stock Market
- Insiders
- Stephen Toon